Authors:
OLLIFF S
SEYMOUR L
POOLE C
DETAKATS P
ORME R
FERRY D
KERR D
Citation: S. Olliff et al., EVALUATION OF SMANCS YRENE-CO-MALEYL-HALF-N-BUTYLATE)-NEOCARZINOSTATIN) IN TREATMENT OF INOPERABLE HEPATOCELLULAR-CARCINOMA, Annals of oncology, 9, 1998, pp. 676-676
Citation: S. Cowell et P. Detakats, MATRIX METALLOPROTEINASE PRODUCTION AND IN-VITRO INVASION IN A COLON-CANCER MODEL, British Journal of Cancer, 78, 1998, pp. 61-61
Authors:
CLEMONS MJ
MARSHALL E
DURIG J
WATANABE K
HOWELL A
MILES D
EARL H
KIERNAN J
GRIFFITHS A
TOWLSON K
DETAKATS P
TESTA NG
DOUGAL M
HUNTER MG
WOOD LM
CZAPLEWSKI LG
MILLAR A
DEXTER TM
LORD BI
Citation: Mj. Clemons et al., RANDOMIZED PHASE-II STUDY OF BB-10010 (MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA) IN PATIENTS WITH ADVANCED BREAST-CANCER RECEIVING 5-FLUOROURACIL, ADRIAMYCIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY, Blood, 92(5), 1998, pp. 1532-1540
Authors:
FORAN JM
OSCIER D
ORCHARD J
JOHNSON SAN
TIGHE M
CULLEN M
DETAKATS P
KRAUS C
KLEIN M
LISTER TA
Citation: Jm. Foran et al., DOSE-DEPENDENT INCREASE OF THE SYSTEMIC 2F-ARA-A EXPOSURE FOLLOWING SINGLE ORAL DOSES OF 50, 70 AND 90 MG FLUDARABINE PHOSPHATE AS TABLETS, Blood, 90(10), 1997, pp. 1459-1459